IMPDH2 expression has been found to be vastly dysregulated in several cancer types14,20,21, promoting pro-tumorigenic phenotypes and leading to an elevated IMPDH2/IMPDH1 ratio14, while the role of IMPDH1 in cancer is less characterized. The gene discussed is IMPDH1; the disease is cancer.